Migraine Therapeutics Market - Growth, Trends, and Forecast (2020 - 2025)
February 20, 2020 13:33 ET
|
ReportLinker
New York, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Migraine Therapeutics Market - Growth, Trends, and Forecast (2020 - 2025)" -...
Global Pain Therapeutics Market Report 2019: Market Trends & R&D Insights 2017-2023
February 20, 2019 06:55 ET
|
Research and Markets
Dublin, Feb. 20, 2019 (GLOBE NEWSWIRE) -- The "The Global Pain Therapeutics Market, 6th Edition: Market Trends & R&D Insights" report has been added to ResearchAndMarkets.com's ...
Pernix® Therapeutics Reports Third Quarter 2018 Financial Results
November 08, 2018 16:01 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, announced today its financial results for the three and nine...
Pernix Therapeutics Reports Second Quarter 2018 Financial Results
August 09, 2018 16:01 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, announced today its financial results for the three and...
Pernix Therapeutics Reports First Quarter 2018 Financial Results
May 10, 2018 16:01 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today its financial results for the three months...
Pernix Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
March 08, 2018 16:01 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today financial results for the three and twelve...
Pernix Therapeutics Announces Launch of Authorized Generic Version of Treximet® by Company’s Subsidiary, Macoven Pharmaceuticals
February 16, 2018 16:01 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced the launch of an authorized generic version...
Pernix Announces Reorganization of Sales Force to Focus on Zohydro® ER with BeadTek™ and Silenor®
January 05, 2018 08:30 ET
|
Pernix Therapeutics Holdings, Inc.
Anticipated Cost Savings of $7-$8 Million MORRISTOWN, N.J., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced...
Pernix Therapeutics Reports Third Quarter 2017 Financial Results
November 07, 2017 16:01 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, announced today financial results...
Pernix Therapeutics Announces Planned Departure of Chief Financial Officer
October 17, 2017 16:05 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced that Graham Miao,...